Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism

BACKGROUND: There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolipoprotein(a) polymorphism are associated with angiographically assessed asymptom...

Descrición completa

Detalles Bibliográficos

Publicado en:	Cardiovasc Diabetol
Principais autores:	Gazzaruso, Carmine, Garzaniti, Adriana, Giordanetti, Stefano, Falcone, Colomba, Fratino, Pietro
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2002
Assuntos:	Original Investigation
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC149426/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12473160/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1475-2840-1-5
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!